Knowledge of Risk Among Patients at Increased Risk for Stroke
Stroke 28:916-921, Samsa,G.P.,et al, 1997
Practice Guidelines for the Use of Imaging in Transient Ischemic Attacks and Acute Stroke
Stroke 28:1480-1497, Culebras,A.,et al, 1997
Attitudes of US Neurologists Concerning the Ethical Dimensions of Managed Care
Neurol 49:4-13, Bernat,J.L.,et al, 1997
Managed Care and Neurologists:Ethical Considerations
Ethics & Humanities Subcomm of Practice Comm of AAN, Neurol 49:321-32297., , 1997
Anticytokine Antibodies in Beta Interferon-Trated MS Patients and the Need for Testing
Neurol 49:647-650, Pachner,A.R., 1997
Silicone Breast Implants and Neurologic Disorders
Neurol 48:1504-1507, Ferguson,J.H., 1997
ALS Standard of Care Consensus
Neurol 48 (Suppl 4) :S33-S37997., Miller,R.G.,et al, 1997
Practice Advisory on the Trtm of ALS with Riluzole
Quality Standards Subcommittee of the AAN, Neurol 49:657-6591997., , 1997
Assessment of Digital EEG, Quantitative EEG, and EEG Brain Mapping
Neurol 49:277-292, Nuwer,M., 1997
Diagnosing Syncope, Part 2:Unexplained Syncope
Ann Int Med 127:76-86, Linzer,M.,et al, 1997
Practice Parameter:Genetic Testing Alert
Pract Comm Genet Testing Task Force AAN, Neurol 47:1343-13441996., , 1996
Guidelines for Physicians with Patients on IFNB-1b:The Use of an Assay for Neutralizing Antibodies (NAB)
Neurol 47:865-866, Paty,D.,et al, 1996
Interferon Beta in Multiple Sclerosis
BMJ 313:1159, 1157, 1195996., Richards,R.G., 1996
Evaluation of Dementia
NEJM 335:330-336, 19961996., Geldmacher,D.S.&Whitehouse,P.J., 1996
Living with Parkinson's Disease
NEJM 334:114-116, Salzman,E.W., 1996
Streptokinase for Acute Ischemic Stroke with Relationship to Time of Administration
JAMA 276:961-966, 9951996., Donnan,G.A.,et al, 1996
Subjective Memory Complaints May Announce Dementia
Neurol 46:121-125, Schmand,B.,et al, 1996
Agreement on Disease-Specific Criteria for Do-Not-Resuscitate Orders in Acute Stroke
Stroke 27:232-237, Alexandrov,A.V.,et al, 1996
Intraarterial Thrombolysis in Vertebrobasilar Occlusion
AJNR 17:255-262, Becker,K.J.,et al, 1996
Management of Patients Receiving Interferon Beta-1b for MS:Report of a Consensus Conf
Neurol 46:12-18, Lublin,F.D.,et al, 1996
Factors Delaying Hospital Admission After Acute Stroke
Stroke 27:398-400, Fogelholm,R.,et al, 1996
Consensus Statement on the Definition of Orthostatic Hypotension, Pure Autonomic Failure, and Multiple System Atrophy
Neurol 46:1470, Schatz,I.J.,et al, 1996
Thrombolytic Therapy with Streptokinase in Acute Ischemic Stroke
The MAST-E Study Group, NEJM 335:145-1501996., , 1996
Thrombolytic Therapy for Acute Ischemic Stroke-Summary Statement
Report of the Quality Standards Subcommittee of the AAN, Neurol 47:835-8391996., , 1996
Factors Delaying Hospital Admission in Acute Stroke:The Copenhagen Stroke Study
Neurol 47:383-387, Jorgensen,H.S.,et al, 1996
US Nat'l Survey of Phy Pract for 2nd & Tertiary Prevent of Ischemic Stroke, Med Therapy in Carotid Art Stenosis
Stroke 27:1473-1478, Goldstein,L.B.,et al, 1996
Implementation of an Acute Stroke Program Decreases Hospitalization Costs and Length of Stay
Stroke 27:1040-1043, Wentworth,D.A.&Atkinson,R.P., 1996
Results of a Computerized Screening of Stroke Patients for Unjustified Hospital Stay
Stroke 27:639-644, Goldman,R.S.,et al, 1996
Apolipoprotein E Genotyping in Alzheimer's Disease
Lancet 347:1091-1095, Tanzi,R.,et al, 1996
Family Members'Attitudes Toward Telling the Patient with Alzheimer's Disease Their Diagnosis
BMJ 313:529-530, Maguire,C.P.,et al, 1996
US NEurologists:Attitudes on the US Health Care System
Neurol 47:279-287, Ringel,S.P.,et al, 1996
Evidence-Based Medicine, Critical Pathways, Practice Guidelines, & Managed Care:Prevention & Care of Stroke
Arch Neurol 53:867-871, Ringel,S.P.&Hughes,R.L., 1996
Assessment of Plasmapheresis
Report of the Therapeutics and Technology Assessment Subcommittee of the AAN, Neurol 47:840-8431996., , 1996
Problems with Myofascial Pain Syndrome and Fibromyalgia Syndrome
Neurol 46:593-597, Bohr,T., 1996
Intravenous Immunoglobulin Treatment of Neurological Disease
JNNP 60:359-361, Otten,A.,et al, 1996
Cost-Effectiveness Analysis:What Is It and How Will It Influence Neurology
Ann Neurol 39:818-823, Holloway,R.G., 1996
Practice Parameters for the Diagnosis of Patients with Nervous System Lyme Borreliosis (Lyme Disease)
Neurol 46:619-627, 8811996., Halperin,J.J.,et al, 1996
Neuroimaging in the Emergency Patient Presenting with Seizure
Neurol 47:26-32, 2881996., Greenberg,M.K.,et al, 1996
Assessment:Electronystagmography, Report of the Therapeutics and Technology Assessment Subcommittee
Neurol 46:1763-1766, Ferguson,J.H.,et al, 1996
Practice Parameter:A Guideline for Discontinuing Antiepileptic Drugs in Seizure-Free Patients-Summary Statement
Neurol 47:600-602, Rosenberg,J.H., 1996
Practice Parameter:The Neurodiagnostic Evaluation of the Child with First Simple Febrile Seizure
Pediatrics 97:769-772, Bergman,D.A.,et al, 1996
Patient Awareness of Seizures
Neurol 47:260-264, Blum,D.E.,et al, 1996
Patterns of Ordering Diagnostic Tests for Patients with Acute Low Back Pain
Ann Int Med 125:807-814, Carey,T.S.,et al, 1996
Epilepsy and Sudden Death
Lancet 348:1324-1325, Nashef,L.&Brown,S., 1996
Statement of Use of Apolipoprotein E Testing for Alzheimer Disease
JAMA 274:1627-1629, Farrer,L.A.,et al, 1995
Thrombolysis and Low Back Pain
BMJ 310:504, Fishwick,D.,et al, 1995
Embolic Stroke Following Thrombolytic Therapy for Myocardial Infarction in a Patient with Preexisting Ventricular Thrombi
Stroke 26:324-325, Bautista,R.E.D., 1995
Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator for Acute Hemispheric Stroke:The ECASS
JAMA 274:1017-1025, 10581995., Hacke,W.,et al, 1995
Tissue Plasminogen Activator for Acute Ischemic Stroke
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, NEJM 333:1581-1587, 12,1995., 1995
Randomised Contr Trial of Streptokinase
Aspirin & Comb in Trtm of Acute Ischaemic Stroke, Multictr Acute Stroke Trial-Italy, Lancet 346:1509, 15145,1504,1995., 1995